- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
7th grade Avg
|
- 10-K Annual report
- 10.11 Summary of 2005 Compensation for Non-employee Directors
- 10.12 Summary of 2005 Compensation for Named Executive Officers
- 10.13 Letter Concerning Retirement Benefits for Charles E. Golden
- 10.14 Letter Concerning Retirement Benefits for Steven M. Paul
- 10.15 Arrangement Regarding Retirement Benefits
- 10.16 Time Sharing Agreement
- 12 Statement Regarding Computation of Ratio of Earnings
- 13 Annual Report to Shareholders
- 21 List of Subsidiaries
- 23 Consent of Independent Registered Public Accounting Firm
- 31.1 Certification
- 31.2 Certification
- 32 Section 1350 Certification
- 99 Cautionary Statement
EXHIBIT 23
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in this Annual Report (Form 10-K) of Eli Lilly and Company of our reports dated February 14, 2005, with respect to the consolidated financial statements of Eli Lilly and Company, Eli Lilly and Company management’s assessment of the effectiveness of internal control over financial reporting, and the effectiveness of internal control over financial reporting of Eli Lilly and Company, included in the 2004 Annual Report to Shareholders of Eli Lilly and Company.
We consent to the incorporation by reference in the following Registration Statements:
Registration Statement No. | Type of Statement | Date | ||
33-37341 | S-8 | October 17, 1990 | ||
33-58466 | S-3 | February 17, 1993 | ||
33-50783 | S-8 | October 27, 1993 | ||
33-56141 | S-8 | October 24, 1994 | ||
333-02021 | S-8 | March 28, 1996 | ||
333-62015 | S-8 | August 21, 1998 | ||
333-66113 | S-8 | October 26, 1998 | ||
333-90397 | S-8 | November 5, 1999 | ||
333-35248 | S-3 | April 20, 2000 | ||
333-70308 | S-8 | September 27, 2001 | ||
333-104057 | S-8 | March 27, 2003 | ||
333-106478 | S-3/A | September 16, 2003; |
of our reports dated February 14, 2005, with respect to the consolidated financial statements of Eli Lilly and Company, Eli Lilly and Company management’s assessment of the effectiveness of internal control over financial reporting, and the effectiveness of internal control over financial reporting of Eli Lilly and Company incorporated by reference in the 2004 Annual Report (Form 10-K) of Eli Lilly and Company.
/s/ Ernst & Young LLP
Indianapolis, Indiana
March 4, 2005